Kabut, J.; Stopyra, M.; Nafalska, N.; Stępień, G.J.; Miciak, M.; Jezierzański, M.; Furgoł, T.; Feret, K.; Gisterek-Grocholska, I.
mRNA-Based Neoantigen Vaccines in Pancreatic Ductal Adenocarcinoma (PDAC)—A Promising Avenue in Cancer Immunotherapy. Int. J. Mol. Sci. 2025, 26, 10988.
https://doi.org/10.3390/ijms262210988
AMA Style
Kabut J, Stopyra M, Nafalska N, Stępień GJ, Miciak M, Jezierzański M, Furgoł T, Feret K, Gisterek-Grocholska I.
mRNA-Based Neoantigen Vaccines in Pancreatic Ductal Adenocarcinoma (PDAC)—A Promising Avenue in Cancer Immunotherapy. International Journal of Molecular Sciences. 2025; 26(22):10988.
https://doi.org/10.3390/ijms262210988
Chicago/Turabian Style
Kabut, Jacek, Małgorzata Stopyra, Natalia Nafalska, Grzegorz J. Stępień, Michał Miciak, Marcin Jezierzański, Tomasz Furgoł, Krzysztof Feret, and Iwona Gisterek-Grocholska.
2025. "mRNA-Based Neoantigen Vaccines in Pancreatic Ductal Adenocarcinoma (PDAC)—A Promising Avenue in Cancer Immunotherapy" International Journal of Molecular Sciences 26, no. 22: 10988.
https://doi.org/10.3390/ijms262210988
APA Style
Kabut, J., Stopyra, M., Nafalska, N., Stępień, G. J., Miciak, M., Jezierzański, M., Furgoł, T., Feret, K., & Gisterek-Grocholska, I.
(2025). mRNA-Based Neoantigen Vaccines in Pancreatic Ductal Adenocarcinoma (PDAC)—A Promising Avenue in Cancer Immunotherapy. International Journal of Molecular Sciences, 26(22), 10988.
https://doi.org/10.3390/ijms262210988